Company news
Rockwell Medical, Inc. (NASDAQ:RMTI) news
Rockwell Medical, Inc. news releases on 6ix. Latest, Nov 14, 2023: Rockwell Medical Announces Third Quarter 2023 Results
Press releases — page 2
Rockwell Medical Announces Third Quarter 2023 Results
November 13, 2023
Rockwell Medical Names Jesse Neri as Senior Vice President, Finance
October 17, 2023
Rockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of Directors
October 16, 2023
Rockwell Medical to Release Third Quarter 2023 Results on Tuesday, November 14, 2023
October 15, 2023
Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care
October 2, 2023
Rockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services; Expands Distribution Capabilities Westward into Utah
September 27, 2023
Rockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024
September 20, 2023
Rockwell Medical Announces Second Quarter 2023 Results
August 13, 2023
Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 8, 2023
Rockwell Medical to Release Second Quarter 2023 Financial Results on Monday, August 14, 2023
July 16, 2023
Rockwell Medical Acquires Hemodialysis Concentrates Business from Evoqua Water Technologies
July 10, 2023
Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical
June 28, 2023
Rockwell Medical Announces First Quarter 2023 Results
May 14, 2023
Rockwell Medical Announces Global Expansion into the United Arab Emirates
April 30, 2023
Rockwell Medical Announces Fourth Quarter and Full-Year 2022 Financial and Operational Results
March 29, 2023
Rockwell Medical Signs Three-Year, Multi-Million Dollar Supply Agreement with Largest Non-Profit Dialysis Provider in the United States
February 1, 2023
Rockwell Medical Begins Selling its Hemodialysis Concentrates Products to New Clinics in Minnesota with its Largest Customer
December 12, 2022
Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational Results
November 13, 2022
Rockwell Medical Reacquires Distribution Rights for its Hemodialysis Concentrates Business from Baxter
November 8, 2022
Rockwell Medical to Release Third Quarter 2022 Financial Results on Monday, November 14
October 16, 2022
Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
September 13, 2022
Rockwell Medical Names Heather Hunter SVP, Chief Corporate Affairs Officer
September 6, 2022
Rockwell Medical Announces Second Quarter 2022 Results
August 14, 2022
Rockwell Medical Provides Corporate and Clinical Update
June 21, 2022
Rockwell Medical, Inc. Appoints Mark Strobeck, Ph.D., as President and Chief Executive Officer
June 21, 2022
Rockwell Medical Closes $15 Million Financing from Leading Healthcare Investor
June 6, 2022
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements
May 31, 2022
Rockwell Medical Announces $15 Million At-Market Offering
May 30, 2022
Rockwell Medical Provides First Quarter 2022 Financial and Operational Update
May 15, 2022
Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial
May 11, 2022
Rockwell Medical Announces 1-for-11 Reverse Stock Split
May 11, 2022
Rockwell Medical Announces Completion of Patient Enrollment Ahead of Schedule in Pivotal Phase 3 Clinical Trial of Triferic® in China
April 24, 2022
Rockwell Medical Announces Upcoming Poster Presentation at the National Home Infusion Association’s 2022 Annual Conference
March 8, 2022
Rockwell Medical Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 13, 2022
Rockwell Medical Announces Regulatory Approval of Triferic® Dialysate in South Korea
January 19, 2022
Rockwell Medical Announces Regulatory Approval of Triferic® AVNU in South Korea
January 12, 2022
Rockwell Medical Receives Important Feedback from FDA on its IND Application for Phase 2 Trial of Ferric Pyrophosphate Citrate in Home Infusion
December 13, 2021
Rockwell Medical, Inc. Provides Third Quarter 2021 Financial and Operational Update
November 14, 2021
Rockwell Medical Submits Investigational New Drug Application with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
November 10, 2021
Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
August 18, 2021
Rockwell Medical, Inc. Provides Second Quarter 2021 Financial and Operational Update
August 15, 2021
Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
June 27, 2021
Rockwell Medical Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis Concentrates
June 10, 2021
Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic® in Turkey
June 7, 2021
Rockwell Medical, Inc. Provides First Quarter 2021 Financial and Operational Update
May 16, 2021
Rockwell Medical Announces Marketing Approval of Triferic® AVNU™ in Canada
April 26, 2021
Rockwell Medical, Inc. Provides Fourth Quarter and Full Year 2020 Financial and Operational Update
March 30, 2021
Rockwell Medical, Inc. to Report Fourth Quarter and Full Year 2020 Financial and Operating Results on March 31, 2021
March 17, 2021
Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis
February 8, 2021
Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd.
January 31, 2021